Bristol Myers Squibb Stock Working Capital
| BMYB34 Stock | BRL 355.25 12.45 3.63% |
Bristol Myers Squibb fundamentals help investors to digest information that contributes to Bristol Myers' financial success or failures. It also enables traders to predict the movement of Bristol Stock. The fundamental analysis module provides a way to measure Bristol Myers' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bristol Myers stock.
Bristol |
Bristol Myers Squibb Company Working Capital Analysis
Bristol Myers' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, Bristol Myers Squibb has a Working Capital of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Drug Manufacturers - Major industry. The working capital for all Brazil stocks is 100.0% higher than that of the company.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Bristol Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0613 | |||
| Profit Margin | 0.14 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 1.04 T | |||
| Shares Outstanding | 2.13 B | |||
| Price To Earning | 50.79 X | |||
| Price To Book | 5.00 X | |||
| Price To Sales | 18.62 X | |||
| Revenue | 46.16 B | |||
| Gross Profit | 36.02 B | |||
| EBITDA | 18.54 B | |||
| Net Income | 6.33 B | |||
| Cash And Equivalents | 29.36 B | |||
| Cash Per Share | 17.95 X | |||
| Total Debt | 39.6 B | |||
| Debt To Equity | 159.70 % | |||
| Current Ratio | 3.88 X | |||
| Book Value Per Share | 15.38 X | |||
| Cash Flow From Operations | 16.21 B | |||
| Earnings Per Share | 15.61 X | |||
| Price To Earnings To Growth | 2.41 X | |||
| Number Of Employees | 41 | |||
| Beta | 0.42 | |||
| Market Capitalization | 812.44 B | |||
| Total Asset | 109.31 B | |||
| Z Score | 12.0 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 109.31 B | |||
| Last Dividend Paid | 2.19 |
About Bristol Myers Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bristol Myers Squibb's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bristol Myers using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bristol Myers Squibb based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Bristol Stock
When determining whether Bristol Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.